CD155 links tumor immunotype to epithelial-directed precision therapy beyond checkpoint inhibition in cervical cancer.

Moreover, it was the only parameter with peak expression in the immune-desert group, although this difference did not reach statistical significance ( figure 5C and online supplemental figure 5B,C ).

also in 111,027 other papers